Purchase Order 36C26325P1086

Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Minneapolis, MN 55417, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The $34,000.00 firm fixed-price purchase order is for the delivery of TAVR (Transcatheter Aortic Valve Replacement) products, with a performance period through September 12, 2025. The contract was awarded on August 13, 2025 without any set-aside designation. Edwards Lifesciences LLC is a...
This $34,000 firm-fixed price purchase order was awarded by the Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company subsidiary of Edwards Lifesciences Corporation. The contract is for the provision of transcatheter aortic valve replacement (TAVR) products and services, with a period of performance through October 2024. This award was not set aside for any small business or socioeconomic category. Edwards Lifesciences LLC has received numerous...
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order contract valued at $34,000.00 to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The contract is for the delivery of Transcatheter Aortic Valve Replacement (TAVR) products, which are specialized cardiovascular medical devices used to enhance surgical and cardiovascular care for veterans. This award is part of a larger Indefinite Delivery...
This federal contract award is for a Purchase Order issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The contract, valued at $34,000.00, is for the delivery of TAVR (Transcatheter Aortic Valve Replacement) products. The contract has an ultimate completion date of July 28, 2025 and is structured as a firm fixed-price arrangement. Edwards Lifesciences LLC is a critical...
The U.S. Department of Veterans Affairs (VA) awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC, a for-profit limited liability company, for transcatheter aortic valve replacement (TAVR) services. The contract has a completion date of November 20, 2024 and does not utilize a set-aside designation. This award is part of Edwards Lifesciences LLC's broader work supporting the VA's Veteran Integrated Service Network (VISN) 23, which covers facilities in Minnesota. The...
This federal contract award, valued at $34,000, was issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The contract is for the provision of TAVR (Transcatheter Aortic Valve Replacement) products and is structured as a firm fixed-price purchase order. It has an ultimate completion date of June 20, 2025. Edwards Lifesciences LLC is a global leader in medical innovations for...
This is a $34,000 firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and small disadvantaged business. The award is for the provision of transcatheter aortic valve replacement (TAVR) products and services, with a completion date of November 6, 2024. The contract is not associated with a set-aside program. Edwards Lifesciences LLC has received numerous prior prime contract awards from the VA and...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company, for the provision of transcatheter aortic valve replacement (TAVR) products. The contract has a ceiling value of $34,000.00 and a performance period ending on May 12, 2025. Edwards Lifesciences LLC is the sole manufacturer of the required heart valve products and holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is a $34,000 firm fixed-price purchase order issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The contract is for the delivery of TAVR (Transcatheter Aortic Valve Replacement) products, with a performance period through September 8, 2025. Edwards Lifesciences LLC is a major supplier of specialized cardiovascular medical devices to the VA and...
This federal contract award is a purchase order valued at $34,000 issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company subsidiary of Edwards Lifesciences Corporation, a global leader in medical devices for structural heart disease and critical care monitoring. The contract is for the provision of transcatheter aortic valve replacement (TAVR) products and services, with a period of performance ending on January 22, 2025....

This federal contract award was made by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The $34,000.00 firm fixed-price purchase order is for the delivery of Transcatheter Aortic Valve Replacement (TAVR) products, with a performance period through August 26, 2025. The contract is not associated with any set-aside designation.

In addition to this purchase order, Edwards Lifesciences LLC holds two significant Indefinite Delivery Contracts (IDCs) with the VA, valued at $4,261,359.80 and $1,870,000, for the procurement of TAVR Heart Valves and SAPIEN 3 RESILIA Heart Valves, respectively. These IDCs further demonstrate the company's critical role in providing advanced cardiovascular technologies to the VA healthcare system.

Generated 8/31/25, 1:05 AM